Skip to main content
. 2023 Sep 8;13:1256537. doi: 10.3389/fonc.2023.1256537

Figure 3.

Figure 3

Clinical applications of ncRNAs in LC. The dysregulated ncRNAs are identified from LC patient samples using RNA sequencing and bioinformatics. In vitro and in vivo studies are performed to further clarify the underlying mechanisms of these ncRNAs involved in LC progression. Large patient cohorts are used to validate their potential as diagnostic and prognostic biomarkers. Novel ncRNA-based therapeutic strategies are developed for LC patients.